Your browser doesn't support javascript.
Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data.
Zhao, Jinqiu; Li, Xiaosong; Huang, Wenxiang; Zheng, Junyi.
  • Zhao J; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, No. 1 Yi Xue Yuan Road, Yuzhong District, Chongqing 400016, China.
  • Li X; Laboratory medicine, The First Affiliated Hospital of Chongqing Medical University, No. 1 Yi Xue Yuan Road, Yuzhong District, Chongqing 400016, China.
  • Huang W; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, No. 1 Yi Xue Yuan Road, Yuzhong District, Chongqing 400016, China.
  • Zheng J; Department of Endocrinology, Chongqing General Hospital, No.104 Pipashan Street, Yuzhong District, Chongqing 400014, China. Electronic address: zjy18996@163.com.
Am J Emerg Med ; 38(11): 2374-2380, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-716508
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Since the first case of the pneumonia caused by 2019 novel coronavirus (COVID-19) is found in Wuhan, there have been more than 70,000 cases reported in China. This study aims to perform the meta-analysis of risk factors for the case fatality rate (CFR) of the 2019 novel coronavirus (COVID-19). DESIGN AND

METHODS:

We have searched PubMed, Google scholar and medRxiv for the cohort studies involving risk factors for the CFR of COVID-19. This meta-analysis compares the risk factors of CFR between fatal patients and non-fatal patients.

RESULTS:

Two cohort studies are included in this study. After comparing the patients between fatal cases and non-fatal cases, several important factors are found to significantly increase the CFR in patients with COVID-19, and include the age ranging 60-70 (OR = 1.85; 95% CI = 1.62 to 2.11; P < .00001) and especially≥70 (OR = 8.45; 95% CI = 7.47 to 9.55; P < .00001), sex of male (OR = 1.88; 95% CI = 1.30 to 2.73; P = .0008), occupation of retirees (OR = 4.27; 95% CI = 2.50 to 7.28; P < .00001), and severe cases (OR = 691.76; 95% CI = 4.82 to 99,265.63; P = .01). As the advancement of early diagnosis and treatment, the CFR after January 21 (or 22), 2020 is substantially decreased in COVID-19 than before (OR = 0.21; 95% CI = 0.19 to 0.24; P < .00001).

CONCLUSIONS:

Several factors are confirmed to significantly improve the CFR in patients with COVID-19, which is very important for the treatment and good prognosis of these patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Risk Factors / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Am J Emerg Med Year: 2020 Document Type: Article Affiliation country: J.ajem.2020.08.039

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Risk Factors / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Am J Emerg Med Year: 2020 Document Type: Article Affiliation country: J.ajem.2020.08.039